Those who are unfamiliar with Israeli’s top-notch technology are often surprised to hear about Israeli innovations that range from electronics and green technology to biotech and semiconductors. It is undeniable that Israeli technology is in your cell phone, computer, and medicine cabinet. Israel, in fact, has created more medical devices per capita than any other country in the world.

Israeli founded Kite Pharmaceutical is currently developing a cure for cancer using the body’s own immune cells to fight the cancer. Last year the FDA approved Kite Pharm’s Yescarta, which was designed to fight a type of lymphoma. The medication was developed at Israel’s Weizmann Institute of Science.

Mazor Robotics is an Israeli medical device company and manufacturer of a robotic guidance system for spine and brain surgery. Their first product, SpineAssist, was approved by the FDA in 2004 and has since been used in thousands of spine surgeries. Rewalk, a bionic walking system, allows paraplegics to stand upright.

Another Israeli based company, OrCam Technologies, develops and manufactures assisted technology devices for individuals who are visually impaired or have other disabilities. OrCam has developed Myeye, a portable, artificial vision device that allows the visually impaired to understand text and identify objects through audio descriptions of things they cannot see.

Israel is at the cutting edge of world class technology that helps save lives and improves medical care dramatically. Israeli companies are equipping hospitals with lifesaving devices and are releasing medicines that greatly improve quality of life and shape the future of how we fight disease. Israeli scientists are also developing a new technology for diagnosing cancer using a patient’s urine and breath, to identify tumors even before they are visible on X-rays.

Israeli company Oramed Pharmaceuticals is currently in late-stagehuman trials of their oral insulin capsule. Oramed (NASDAQ: ORMP) has developed a game-changing drug that potentially enables patients with diabetes to administer their insulin orally rather than via injection. This groundbreaking research has the potential to expand into other injectable medications and enhance their oral delivery to better fight disease.

Oramed’s CEO Nadav Kidron explains, “Currently, more than 9% of the US population suffers from diabetes. Oral insulin is an opportunity to greatly improve the quality of life of those suffering from the disease. This technology can transition into other treatments that are currently only treated via injection, and potentially treat these diseases not just more conveniently, but more effectively by utilizing the body’s own natural cycle of absorption. I feel a great sense of pride representing Israel in a capacity that helps improve the quality of life of people around the world. My father suffered from diabetes and it was my mother’s mission to find an alternative way to deliver insulin. When she told me that they had a breakthrough that could help millions of people around the world, that’s when I knew I had to make it a reality and ease their suffering. The world is watching everything Israel does, and when they look to see who we are, they will see that we are changing the world for the better.”

Former Israeli President Shimon Peres stated upon the opening of the Israeli Innovation Center in 2016, “Our innovative spirit has been recognized all over the world and, of course, my heart swells with pride when I see how many nations turn to the tiny State of Israel to learn from our bold innovations and to learn how to turn the impossible into the possible. Innovation enables dialogue between nations and between people. It will enable all young people to engage in science and technology equally.”

Nadav Kidron is currently living in NYC and tours the country speaking abou­­t Israeli innovation. He can be reached via his website at